Condition: COPD Bronchitis · Pollution Related Respiratory Disorder · Sponsor: National Institute of Respiratory Diseases, Mexico
This phase IV randomized controlled clinical trial intend to compare the effect of three close standard inhaled triple therapies and one close standard inhaled double therapy on the small airway in patients with Chronic Obstructive Pulmonary Disease (COPD-B) and chronic bronchitis without obstruction (BCNO) exposed to wood smoke. The treatment phase duration is of 3 months. As primary outcome, the resistance change in post-bronchodilatator impulse oscilometry will me measure at 30 minutes, 2 hours, 4 hours, and 24 hours post first dose of the asigned medication, and then at 1 and 3 months of treatment. As secondary outcomes, change in respiratory symptoms and health related quality of life will be assess after 1 and 3 months of treatment.
This description comes directly from the study's public registry record.
Alejandra Ramírez-Venegas, MCs · +52 55 54 87 17 00 · aleravas@hotmail.com
Rogelio Pérez-Padilla, Dr · +52 55 54 87 17 00
Always discuss trial participation with your own doctor first.
| Insituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" | Mexico City, Tlalpan, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06571942